Skip to main content

The rockefeller university

News & HighlightsNews
Paul Cohen, expert on fat, is promoted to associate professor
Cohen, a physician-scientist exploring obesity and metabolic disease, has conducted groundbreaking research on the complex inner workings of fat tissue.
Immunologist Daniel Mucida promoted to professor
A pioneer in the field of mucosal immunology, Mucida is unlocking the secrets of the digestive system and answering fundamental questions about the origins of human disease.
Mary Jeanne Kreek, pioneer in studies of addiction, has died
Kreek conducted landmark studies that led to the establishment of methadone as a treatment for heroin addiction. Her work not only yielded new treatments for addiction disorders, but also influenced societal attitudes toward them. She was 84.
Paula Volent is named chief investment officer
The university has named its next vice president and chief investment officer. Volent, who for decades oversaw investments at Bowdoin College, will assume stewardship of Rockefeller's endowment in August.
How one patient’s rare mutation helped solve a mycobacterial mystery
The discovery may explain why some patients suffer more severe reactions than others—putting us one step closer to understanding how our DNA influences our susceptibility to a wide range of infectious diseases.
Financial crashes, pandemics, Texas snow: How math could predict "black swan" events
Statistical modeling may one day help scientists anticipate and manage a wide range of extreme occurrences, according to a new study.
An old antibiotic may combat drug-resistant tuberculosis
Drug-resistant strains of tuberculosis bacteria affect half a million people a year. A compound first discovered in the 1980s may be able to help.
Why male mosquitoes leave humans alone
Unlike their female counterparts, male mosquitoes have no desire to bite us. But the hardware for host-seeking is hidden in the male mosquito brain, locked behind a simple genetic switch. 
This fish is about to flip 
An elaborate set of zebrafish experiments is shining light on one of neuroscience’s greatest enigmas: How brains make decisions. By tracking neural activity, scientists can now predict a fish’s next move before it happens.
Rockefeller grants commercial license for the development of monoclonal antibodies for treatment of COVID-19
The treatment, a combination of two antibodies, has been shown highly capable of neutralizing SARS-CoV-2 in preclinical studies. Researchers hope it will give countries around the world, including developing countries, a way to control the rampant disease.
View
View